Skip to content
Medical Health Aged Care

ALERT – Whooping Cough Day Sat 8 Nov – Canberra Immunisation clinic and call for national approach to lift uptake of vaccinations in pregnancy

Immunisation Foundation of Australia < 1 mins read

This weekend, Canberra will be the centre of a national push to help lift the rate of vaccinations in pregnancy.

To mark Whooping Cough Day (8 November), the Immunisation Foundation of Australia, founded by mother Catherine Hughes AM, who lost her four-week-old son Riley to whooping cough, will host a pop-up vaccination clinic at the Canberra Pregnancy, Babies & Children’s Expo (Saturday 8 and Sunday 9 November).

The clinic will offer information on recommended vaccinations in pregnancy and the opportunity for eligible expectant mums to receive vaccinations.

The clinic coincides with the launch of a new national Maternal Immunisation in Australia whitepaper which highlights a critical gap in Australia's national immunisation approach.  Whilst we have national targets for childhood immunisation, none exist for maternal vaccination.

Experts say national maternal immunisation targets would help ensure every expectant mother in Australia receives consistent information and easy access to vaccination, no matter where she lives or how she receives care.

This is a strong local story with national significance and an important public health message.

Key vision opportunities:

  • Catherine Hughes speaking with expectant parents at the Canberra Expo
  • Pregnant women receiving vaccinations on-site
  • Families engaging with health experts at the Immunisation Foundation of Australia stall

For further information, to arrange an interview with Catherine on-site or coordinate filming opportunities at the Expo on Saturday 8 November please contact: 

Nicki Sambuco at [email protected] or on +61 (0) 452 446 084

Chloe Danvers at [email protected] or on +61 (0) 466 626 429

More from this category

  • Medical Health Aged Care
  • 04/03/2026
  • 10:56
Roots

Roots Corporation Announces Strategic Review

TORONTO–BUSINESS WIRE– Roots Corporation (“Roots,” or the “Company”) (TSX: ROOT) announced that its Board of Directors (the “Board”) has initiated a review of strategic…

  • Contains:
  • Medical Health Aged Care
  • 04/03/2026
  • 08:56
Monash University

Monash University and Seaport Therapeutics Awarded up to $21 Million AUD from ARPA-H to Advance GlyphCeleTM, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash Institute of Pharmaceutical Sciences (MIPS), to address dysfunctional gut lymphatics linked to metabolic disease and pancreatic cancer. Monash University has announced the award of support from the Advanced Research Projects Agency for Health (ARPA-H) to advance an oral prodrug of celecoxib – using the GlyphTM platform and designed to deliver therapy directly to the gut lymphatics – aiming to improve lymphatic function and advance the treatment of metabolic disease and pancreatic cancer by directly addressing local inflammation and lymphatic dysfunction. The…

  • Medical Health Aged Care, Women
  • 04/03/2026
  • 06:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer

MEDIA RELEASE: Wednesday,4March2025 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) announces the local opening of theSTRIVEclinical trial– Stratification of Vulvar Squamous Cell Carcinoma by HPV and p53 status to Guide Excisionclinical trial (CCTG Protocol VU.2; ANZGOG Protocol ANZGOG2109/2021). STRIVErepresentsan important stepforward in advancing evidence-based surgical management for women diagnosed with vulvar squamous cell carcinoma (VSCC). About the STRIVE Trial STRIVE is an international, prospective, stratification study designed to refine surgical decision-making for patients withprimary vulvar squamous cell carcinoma(VSCC) based ontumourbiology. The study is led globally by the CCTG and led…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.